Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Replacement hormone therapy in gonadal dysgenesis.

C J Dewhurst, E B de Koos, R M Haines

    British Journal of Obstetrics and Gynaecology
    |May 1, 1975
    PubMed
    Summary

    Ethinyl oestradiol treatment for gonadal dysgenesis can cause endometrial hyperplasia and polyps. Combining estrogen with progestogen therapy may offer a safer alternative for endometrial health in these patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Primary amenorrhead.

    Pediatric annals·2014
    Same author

    The Ornstein-Uhlenbeck third-order Gaussian process (OUGP) applied directly to the un-resampled heart rate variability (HRV) tachogram for detrending and low-pass filtering.

    Medical & biological engineering & computing·2012
    Same author

    An efficient time-varying filter for detrending and bandwidth limiting the heart rate variability tachogram without resampling: MATLAB open-source code and Internet web-based implementation.

    Computational and mathematical methods in medicine·2012
    Same author

    Amenorrhœa and galactorrhœa.

    Proceedings of the Royal Society of Medicine·2010
    Same author

    Spironolactone in the treatment of hirsutism.

    Acta obstetricia et gynecologica Scandinavica·1986
    Same author

    Human amnion in the treatment of vaginal malformations.

    British journal of obstetrics and gynaecology·1986

    Area of Science:

    • Reproductive Endocrinology
    • Gynecologic Pathology

    Background:

    • Gonadal dysgenesis is a condition affecting ovarian development.
    • Estrogen therapy is sometimes used in managing gonadal dysgenesis.
    • Endometrial changes following estrogen therapy require careful monitoring.

    Purpose of the Study:

    • To evaluate endometrial changes in patients with gonadal dysgenesis treated with ethinyl oestradiol.
    • To compare the effects of estrogen-only therapy versus estrogen-progestogen combination therapy on the endometrium.

    Main Methods:

    • Endometrial curettage was performed in patients with gonadal dysgenesis.
    • Histopathological examination of endometrial tissue was conducted.
    • Patients received either ethinyl oestradiol alone or an estrogen-progestogen combination.

    Main Results:

    • Ethinyl oestradiol monotherapy led to cystic glandular hyperplasia in 7/14 patients and endometrial polyps in one.
    • Atypical changes were observed in one patient on ethinyl oestradiol.
    • Estrogen-progestogen combination therapy resulted in normal secretory endometrium in 5/7 patients.

    Conclusions:

    • Estrogen-progestogen combination therapy appears to induce more favorable endometrial changes compared to ethinyl oestradiol alone.
    • The findings suggest a potentially reduced risk of endometrial abnormalities with combined hormone therapy.
    • Careful consideration of hormone therapy regimens is crucial for patients with gonadal dysgenesis.

    Related Experiment Videos